Breast cancer in elderly women. Optimizing the treatment Roberto GennariRiccardo A. Audisio Review 13 September 2007 Pages: 199 - 209
Akt plays an important role in breast cancer cell chemotaxis to CXCL12 Ming ZhaoBarbara M. MuellerIngrid U. Schraufstatter Preclinical Study 09 August 2007 Pages: 211 - 222
Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors Francesca FaggioliSabina SoldatiMaria Grazia Sacco Preclinical Study 09 August 2007 Pages: 223 - 226
Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants Christopher A. PettigrewNicola WayteMelissa A. Brown Preclinical Study 26 September 2007 Pages: 227 - 234
Consensus genes of the literature to predict breast cancer recurrence Martin LaussAlbert KriegnerChrista Noehammer Preclinical Study 26 September 2007 Pages: 235 - 244
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis Kay SavageSamuel LeungJorge S. Reis-Filho Preclinical Study 03 October 2007 Pages: 245 - 256
Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells J-W. XieS. Z. Haslam Preclinical Study 13 September 2007 Pages: 257 - 268
Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy Maria EjmaMarta Misiuk-HojłoWiesława Bartnik Preclinical Study 13 September 2007 Pages: 269 - 271
Differential gene expression profile in breast cancer-derived stromal fibroblasts Christian F. SingerDaphne Gschwantler-KaulichErnst Kubista Preclinical Study 26 September 2007 Pages: 273 - 281
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice Wen-Bo WangYu-Lin ZhouYing-Lin Cao Preclinical Study 26 September 2007 Pages: 283 - 295
Central carbon metabolism in the progression of mammary carcinoma Adam D. RichardsonChen YangJeffrey W. Smith Preclinical Study Open access 19 September 2007 Pages: 297 - 307
A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer August GarinAlexey ManikhasSergey Tjulandin Clinical Trial 13 September 2007 Pages: 309 - 315
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study Rastko GolouhTanja CuferJohn W. M. Martens Clinical Trial 13 September 2007 Pages: 317 - 326
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy Stephen R. D. JohnstonVladimir F. SemiglazovAngela J. Howes Clinical Trial 13 September 2007 Pages: 327 - 335
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial Ian S. DayesMark N. LevineT. J. Whelan Clinical Trial 13 September 2007 Pages: 337 - 342
I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer Krzysztof RożnowskiDanuta Januszkiewicz-LewandowskaJerzy Nowak Clinical Trial 26 September 2007 Pages: 343 - 348
Does high surgeon and hospital surgical volume raise the five-year survival rate for breast cancer? A population-based study Chin-Shyan ChenTsai-Ching LiuYung-Chang Lien Epidemiology 12 September 2007 Pages: 349 - 356
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years Jiachun LuQingyi WeiLi-E Wang Epidemiology 13 September 2007 Pages: 357 - 366
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans Dezheng HuoHee-Jin KimOlufunmilayo I. Olopade Epidemiology 02 October 2007 Pages: 367 - 376
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history Theodore AnagnostopoulosMaroulio PertesiDrakoulis Yannoukakos Epidemiology 28 September 2007 Pages: 377 - 385
CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk Sohee HanKyoung-Mu LeeDaehee Kang Epidemiology 17 October 2007 Pages: 387 - 393
Standardization of pathologic complete response rates in breast cancer treatment Michael KnauerAlexander DeVriesAnton Haid Letter to the Editor 13 September 2007 Pages: 395 - 396